BONE BIOLOGICS CORPORATION (BBLGW)

Every figure this model derived for BBLGW, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2021-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 0 PaymentsToAcquirePropertyPlantAndEquipment 2015-12-31
cash 6,188,319 CashAndCashEquivalentsAtCarryingValue 2023-03-31
current assets 4,436,668 AssetsCurrent 2026-06-30
current liabilities 512,018 LiabilitiesCurrent 2026-06-30
equity 3,924,650 StockholdersEquity 2026-06-30
interest expense 12,059 InterestPaidNet 2021-12-31
revenue 1,070,000,000 Revenues 2021-06-30
sbc 0 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up BBLGW on one particular measure came for.

RatioValue
current ratio8.67
current ratio reported8.67
sbc pct revenue0.0

What to be careful about

What this model itself distrusts about BBLGW's figures. Written by the derivation as it ran, not added afterwards.